Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

8a537b1e-3937-467b-b258-8ed4ddae6550 - samples

ABSTRACT: RRBS data from TRACERx non-small cell lung cancer (NSCLC) tumours and matched normal adjacent tissue. TRACERx (TRAcking Cancer Evolution through therapy (Rx)) is a prospective cohort study designed to investigate intratumor heterogeneity (ITH) in relation to clinical outcome, and to determine the clonal nature of driver events and evolutionary processes in early stage non-small cell lung cancer (NSCLC).

PROVIDER: EGAD00001009707 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Multi-region RNA sequencing of tumour regions and tumour-adjacent normal lung tissue

| EGAS00001006517 | EGA

TRACERx NSCLC - Whole exome multiregion sequencing data

| EGAS00001006494 | EGA

RRBS data from TRACERx non-small cell lung cancer (NSCLC) tumours and matched normal adjacent tissue.

| EGAS00001006523 | EGA

TRACERx 100: RNAseq data from the first 100 TRACERx tumours

| EGAS00001003458 | EGA

TRACERx 100: RRBS data from a subset of the first 100 TRACERx tumours

Project description:TRACERx (TRAcking Cancer Evolution through therapy (Rx)) is a prospective cohort study designed to investigate intratumor heterogeneity (ITH) in relation to clinical outcome, and to determine the clonal nature of driver events and evolutionary processes in early stage non-small cell lung cancer (NSCLC). This study looks at multi-region RRBS data from the TRACERx100 cohort selected for quantity of material available and high tumour purity. RRBS data was collected for 122 tumour regions across 36 patients each with matched normal. A subset of this cohort was used in a sister study looking at tumour neo-antigen promoter methylation status in NSCLC (71 tumour regions across 28 patients for a total of 99 samples).

| EGAS00001003484 | EGA

Homo sapiens

Project description:Intratumor heterogeneity of gene expression profiles in early stage non-small cell lung cancer (NSCLC)

| PRJNA148907 | ENA

Phosphoproteome of NSCLC patient–derived cells.

Project description:Phosphoproteome of anaplastic lymphoma kinase–positive non-small cell lung cancer (ALK+ NSCLC) patient–derived cells.

2024-11-19 | PXD050973 | JPOST Repository

Korean NSCLC Acetylome Subtype Analysis

Project description:Through multidimensional genomic/protein multiomics analysis and clinical information integration of cancer tissue samples, a prognostic method for lung cancer, including non-small cell lung cancer (NSCLC), is developed and applied to precision medical care after discovering new drug targets.

2024-11-01 | PXD053903 | JPOST Repository

Korean NSCLC Phosphoproteome Subtype Analysis

2024-11-01 | PXD053921 | JPOST Repository

Korean NSCLC Global Proteome Subtype Analysis

2024-11-01 | PXD053969 | JPOST Repository